The Role of MRI in the Diagnosis and Treatment of Gastric Cancer

Overview

Journal Diagn Interv Radiol

Publisher Galenos Publishing House

Date 2020 Mar 27

PMID 32209504

Citations 38

Authors

Yingjing Zhang

Jianchun Yu

Affiliations

Soon will be listed here.

Abstract

Gastric cancer is the fifth most common malignancies and the third leading cause of cancer-related death worldwide, with more than 40% of new cases occurring in China. With the advancement of treatment methods, the application of adjuvant therapy and targeted drugs, the prognosis of patients with gastric cancer has been significantly improved. In recent years, more and more studies have reported that magnetic resonance imaging (MRI) showed great value in the clinical application among patients with gastric cancer, including preoperative staging, treatment response evaluation, predicting prognosis and histopathological features, treatment guidance, and molecular imaging. The remarkable research progress of MRI in gastric cancer will provide new evaluation and treatment approaches for clinical diagnosis and treatment. This article aims to review the current status of the application and research progress of MRI in patients with gastric cancer.

Citing Articles

Advancements in non-invasive diagnosis of gastric cancer.

Wang Z, Wu Q World J Gastroenterol. 2025; 31(6):101886.

PMID: 39958452 PMC: 11752698. DOI: 10.3748/wjg.v31.i6.101886.

Advancing gastric cancer treatment: nanotechnology innovations and future prospects.

Yang T, Guo L Cell Biol Toxicol. 2024; 40(1):101.

PMID: 39565472 PMC: 11579161. DOI: 10.1007/s10565-024-09943-9.

Transcriptomics-Based Liquid Biopsy for Early Detection of Recurrence in Locally Advanced Gastric Cancer.

Ding P, Wu J, Wu H, Li T, Niu X, Yang P Adv Sci (Weinh). 2024; 11(47):e2406276.

PMID: 39556695 PMC: 11653671. DOI: 10.1002/advs.202406276.

Clinical application of oral contrast-enhanced ultrasound in evaluating the preoperative T staging of gastric cancer.

Liang Y, Jing W, Song J, Wei Q, Cai Z, Li J World J Gastroenterol. 2024; 30(41):4439-4448.

PMID: 39534423 PMC: 11551674. DOI: 10.3748/wjg.v30.i41.4439.

in the development and treatment of precancerous lesions of gastric cancer.

Qian S, Zhao H, Xie F, Liu Q, Cai D World J Gastrointest Oncol. 2024; 16(9):3771-3780.

PMID: 39350992 PMC: 11438778. DOI: 10.4251/wjgo.v16.i9.3771.

References

Song X, Kang H, Jeong G, Ahn K, Jeong Y, Kang Y . Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer. World J Gastroenterol. 2016; 22(24):5520-31. PMC: 4917612. DOI: 10.3748/wjg.v22.i24.5520. View

Shinya S, Sasaki T, Nakagawa Y, Guiquing Z, Yamamoto F, Yamashita Y . The usefulness of diffusion-weighted imaging (DWI) for the detection of gastric cancer. Hepatogastroenterology. 2007; 54(77):1378-81. View

Giganti F, De Cobelli F, Canevari C, Orsenigo E, Gallivanone F, Esposito A . Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. J Magn Reson Imaging. 2013; 40(5):1147-57. DOI: 10.1002/jmri.24464. View

Caivano R, Rabasco P, Lotumolo A, D Antuono F, Zandolino A, Villonio A . Gastric cancer: The role of diffusion weighted imaging in the preoperative staging. Cancer Invest. 2014; 32(5):184-90. DOI: 10.3109/07357907.2014.896014. View

De Cobelli F, Giganti F, Orsenigo E, Cellina M, Esposito A, Agostini G . Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology. Eur Radiol. 2013; 23(8):2165-74. DOI: 10.1007/s00330-013-2807-0. View

Cunningham D, Allum W, Stenning S, Thompson J, van de Velde C, Nicolson M . Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355(1):11-20. DOI: 10.1056/NEJMoa055531. View

Hwang S, Lee D, Lee S, Park Y, Hwang J, Kim J . Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol. 2010; 25(3):512-8. DOI: 10.1111/j.1440-1746.2009.06106.x. View

Kim A, Kim H, Ha H . Gastric cancer by multidetector row CT: preoperative staging. Abdom Imaging. 2005; 30(4):465-72. DOI: 10.1007/s00261-004-0273-5. View

Corradini S, Alongi F, Andratschke N, Belka C, Boldrini L, Cellini F . MR-guidance in clinical reality: current treatment challenges and future perspectives. Radiat Oncol. 2019; 14(1):92. PMC: 6551911. DOI: 10.1186/s13014-019-1308-y. View

10.

Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M . Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10. Gastric Cancer. 2006; 9(2):120-8. DOI: 10.1007/s10120-006-0365-8. View

11.

Zhong J, Zhao W, Ma W, Ren F, Qi S, Zheng J . DWI as a Quantitative Biomarker in Predicting Chemotherapeutic Efficacy at Multitime Points on Gastric Cancer Lymph Nodes Metastases. Medicine (Baltimore). 2016; 95(13):e3236. PMC: 4998555. DOI: 10.1097/MD.0000000000003236. View

12.

Joo I, Lee J, Kim J, Shin C, Han J, Choi B . Prospective comparison of 3T MRI with diffusion-weighted imaging and MDCT for the preoperative TNM staging of gastric cancer. J Magn Reson Imaging. 2014; 41(3):814-21. DOI: 10.1002/jmri.24586. View

13.

Polkowski M, Palucki J, Wronska E, Szawlowski A, Nasierowska-Guttmejer A, Butruk E . Endosonography versus helical computed tomography for locoregional staging of gastric cancer. Endoscopy. 2004; 36(7):617-23. DOI: 10.1055/s-2004-814522. View

14.

Lee D, Kim S, Im S, Oh D, Kim T, Han J . Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study. Eur Radiol. 2015; 26(8):2771-8. DOI: 10.1007/s00330-015-4105-5. View

15.

Chen Y, Lian G, Liao C, Wang W, Zeng L, Qian C . Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. J Gastroenterol. 2012; 48(7):809-21. DOI: 10.1007/s00535-012-0713-x. View

16.

Bonekamp S, Corona-Villalobos C, Kamel I . Oncologic applications of diffusion-weighted MRI in the body. J Magn Reson Imaging. 2012; 35(2):257-79. DOI: 10.1002/jmri.22786. View

17.

Liu S, Guan W, Wang H, Pan L, Zhou Z, Yu H . Apparent diffusion coefficient value of gastric cancer by diffusion-weighted imaging: correlations with the histological differentiation and Lauren classification. Eur J Radiol. 2014; 83(12):2122-2128. DOI: 10.1016/j.ejrad.2014.09.021. View

18.

Kwee R, Kwee T . Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol. 2007; 25(15):2107-16. DOI: 10.1200/JCO.2006.09.5224. View

19.

Koh D, Collins D . Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007; 188(6):1622-35. DOI: 10.2214/AJR.06.1403. View

20.

Hasbahceci M, Akcakaya A, Memmi N, Turkmen I, Cipe G, Yildiz P . Diffusion MRI on lymph node staging of gastric adenocarcinoma. Quant Imaging Med Surg. 2015; 5(3):392-400. PMC: 4426126. DOI: 10.3978/j.issn.2223-4292.2015.03.06. View